Kewaunee Scientific Corporation (NASDAQ:KEQU – Get Free Report) shares passed below its two hundred day moving average during trading on Wednesday after an insider sold shares in the company. The stock has a two hundred day moving average of $45.34 and traded as low as $43.04. Kewaunee Scientific shares last traded at $44.20, with a volume of 7,139 shares traded.
Specifically, CEO Thomas David Hull III sold 1,854 shares of Kewaunee Scientific stock in a transaction on Monday, September 29th. The stock was sold at an average price of $43.42, for a total value of $80,500.68. Following the transaction, the chief executive officer directly owned 39,719 shares in the company, valued at $1,724,598.98. The trade was a 4.46% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.
Get Kewaunee Scientific alerts:
Analyst Ratings Changes
Separately, Wall Street Zen raised Kewaunee Scientific from a “hold” rating to a “buy” rating in a report on Saturday, July 5th.
Read Our Latest Analysis on Kewaunee Scientific
Kewaunee Scientific Stock Performance
The firm’s 50 day simple moving average is $52.24 and its 200-day simple moving average is $45.34. The company has a market capitalization of $126.85 million, a price-to-earnings ratio of 10.70 and a beta of 0.68. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.63 and a current ratio of 2.32.
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last issued its earnings results on Wednesday, September 10th. The technology company reported $1.10 EPS for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.The business had revenue of $71.10 million during the quarter.
Institutional Investors Weigh In On Kewaunee Scientific
A number of institutional investors have recently bought and sold shares of KEQU. Bank of America Corp DE grew its stake in Kewaunee Scientific by 2,605.9% during the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock valued at $28,000 after acquiring an additional 443 shares in the last quarter. IFP Advisors Inc boosted its holdings in shares of Kewaunee Scientific by 61.5% during the first quarter. IFP Advisors Inc now owns 945 shares of the technology company’s stock worth $37,000 after purchasing an additional 360 shares during the period. Raymond James Financial Inc. purchased a new position in Kewaunee Scientific during the second quarter valued at approximately $60,000. Wedbush Securities Inc. purchased a new position in Kewaunee Scientific during the second quarter valued at approximately $232,000. Finally, Morgan Dempsey Capital Management LLC lifted its position in Kewaunee Scientific by 41.8% in the 2nd quarter. Morgan Dempsey Capital Management LLC now owns 4,229 shares of the technology company’s stock worth $247,000 after buying an additional 1,247 shares in the last quarter. 32.69% of the stock is currently owned by institutional investors and hedge funds.
About Kewaunee Scientific
(Get Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Further Reading
Five stocks we like better than Kewaunee Scientific
What is the Hang Seng index?
Datavault AI: The New AI Contender Backed by Big Funding
A Deeper Look at Bid-Ask Spreads
CoreWeave: Why the New King of AI Infrastructure Has Room to Run
With Risk Tolerance, One Size Does Not Fit All
Top 3 Dividend Achievers for October: High Yields, Growth Ahead